Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.
about
Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive reviewThe human subthalamic nucleus encodes the subjective value of reward and the cost of effort during decision-makingShould impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Mechanisms of body weight fluctuations in Parkinson's disease.Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology updateWeight Gain following Pallidal Deep Brain Stimulation: A PET Study.Target Selection Recommendations Based on Impact of Deep Brain Stimulation Surgeries on Nonmotor Symptoms of Parkinson's DiseaseAsymmetric right/left encoding of emotions in the human subthalamic nucleus.Management of impulse control disorders in Parkinson's disease: Controversies and future approachesLinking reward processing to behavioral output: motor and motivational integration in the primate subthalamic nucleusDeep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of actionFuture of brain stimulation: new targets, new indications, new technology.Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.Parkinson's disease, the subthalamic nucleus, inhibition, and impulsivity.Neuropsychiatric Issues in Parkinson's Disease.Current Topics in Deep Brain Stimulation for Parkinson Disease.Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation.Current applications and limitations of surgical treatments for movement disorders.Deep Brain Stimulation Emergencies: How the New Technologies Could Modify the Current Scenario.Profile of Neuropsychiatric Symptoms in Parkinson's Disease: Surgical Candidates Compared to Controls.Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.Targeting the subthalamic nucleus in a preclinical model of alcohol use disorder.A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation.Personality, dopamine, and Parkinson's disease: Insights from subthalamic stimulation.International validation of a behavioral scale in Parkinson's disease without dementia.Management of impulse control disorders in Parkinson's disease.Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up.Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation.[Surgical strategy to rescue the addicts].Closed Loop Deep Brain Stimulation for PTSD, Addiction, and Disorders of Affective Facial Interpretation: Review and Discussion of Potential Biomarkers and Stimulation Paradigms.Impulsive and compulsive behaviors in Parkinson's disease
P2860
Q21284663-04B9B964-341A-4B3A-A663-56DAFE93B7E0Q27303498-56DCD578-94C5-494C-9D76-A208B99F26F4Q27687503-ACF382B4-D728-49DB-B637-B7B68EB4A8BDQ30248922-40667FA1-FCDB-4FE9-BE77-2B5BAEC8D4C0Q33693961-C6330140-059C-4121-B62C-356766EDA674Q34388686-7D614C25-B468-490E-B531-403882E42B10Q34423280-34AEC083-0089-45E7-A54D-AD3F630192F3Q35987080-CC0CFA17-9442-40E4-A439-5A278FE4106CQ36701655-C4CCAACF-D892-41CB-90C8-44F03633E798Q37261589-B0CB7D41-A148-4A0B-B334-FD21EDC64C70Q37361959-6B03B96F-D938-43DD-AA31-53232B89E58AQ37398133-FE9F3D78-5CF7-426A-8A37-D0E9F4D96DEFQ38125935-70C19719-4AAF-4BCB-A679-F7FBE90F8349Q38152385-3BCCD22D-66AE-4526-8A3A-BB23F55CF302Q38211499-0F7AE4F3-C689-4C53-9575-E06D4AAD0681Q38258234-CFE50F82-B460-415F-B54E-282408F90421Q38799051-D4BDD3B3-F369-4C38-918A-DDC32FA3411CQ38878821-1492F668-5F16-40D7-A70F-31C922CE50AAQ38964782-C4A96275-E0C7-4BB7-91B1-54321055A8B2Q39104200-A338E562-F89C-4860-887D-922A449CB175Q39301681-21F33C98-B9E2-4004-B844-DB14DD7B2FFAQ39988350-6A16B587-ECD7-4A6B-A56C-FF866FFA5F0FQ40530060-03C45383-96BC-4C53-9871-93CC3279D869Q47349956-01F91691-CDD0-4C93-B97F-7AA2615675DCQ47664452-CCB0B394-2783-4996-9497-3F3862792A69Q47847221-8D980BB8-646E-4111-8638-8876493D3ABBQ48088853-3D5D9B25-9CD2-4A0C-AEEF-EF5A798E166CQ48177158-0E247F41-7AA8-4C17-B7DE-CD9FEA76F224Q48615659-9E995C9A-9EC5-4C93-A18C-F600C35D7C1EQ48666119-2B65F4CE-E9AD-4B47-9295-15E84B718A63Q48769110-EE5B7D13-D6ED-4361-B18E-9B50198DA902Q52307362-67E88C8B-5BC0-46E0-BA6E-E4A172DCF292Q55073721-B386B32C-0F09-47D8-8AE4-DCFE3FFB8241Q58492844-B91D794D-5C1D-419F-9F34-A74B5A82BFA9
P2860
Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.
@en
Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.
@nl
type
label
Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.
@en
Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.
@nl
prefLabel
Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.
@en
Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.
@nl
P2093
P2860
P921
P356
P1476
Subthalamic nucleus stimulatio ...... cation in Parkinson's disease.
@en
P2093
Alexandre Eusebio
Elisabeth Jouve
Frédérique Fluchère
Jean Régis
Julien Cohen
Tatiana Witjas
P2860
P304
P356
10.1136/JNNP-2012-302387
P407
P577
2013-02-27T00:00:00Z